Piramal Enterprises Limited (PEL.NS)
INR 954.8
(-0.7%)
INR 954.8
(-0.7%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 535.85 Billion INR | 8.23% |
| 2022 | 495.1 Billion INR | 12.67% |
| 2021 | 439.41 Billion INR | 55.62% |
| 2020 | 282.37 Billion INR | 38.08% |
| 2019 | 204.5 Billion INR | -24.32% |
| 2018 | 270.22 Billion INR | 11.55% |
| 2017 | 242.24 Billion INR | 67.05% |
| 2016 | 145.01 Billion INR | 91.28% |
| 2015 | 75.81 Billion INR | 100.16% |
| 2014 | 37.87 Billion INR | 41.34% |
| 2013 | 26.79 Billion INR | 120.48% |
| 2012 | 12.15 Billion INR | 87.49% |
| 2011 | 6.48 Billion INR | -14.35% |
| 2010 | 7.56 Billion INR | -41.55% |
| 2009 | 12.94 Billion INR | -3.29% |
| 2008 | 13.39 Billion INR | 86.94% |
| 2007 | 7.16 Billion INR | 12.06% |
| 2006 | 6.39 Billion INR | 105.25% |
| 2005 | 3.11 Billion INR | -15.37% |
| 2004 | 3.68 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 575.68 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 535.85 Billion INR | 0.0% |
| 2023 FY | 535.85 Billion INR | 8.23% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 497.99 Billion INR | 0.0% |
| 2022 Q2 | 473.19 Billion INR | 0.0% |
| 2022 Q4 | 495.1 Billion INR | 6.0% |
| 2022 FY | 495.1 Billion INR | 12.67% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | 467.09 Billion INR | -1.29% |
| 2021 Q4 | 439.41 Billion INR | 0.0% |
| 2021 Q2 | 482.66 Billion INR | 0.0% |
| 2021 FY | 439.41 Billion INR | 55.62% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 282.37 Billion INR | 38.08% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 265.67 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 282.37 Billion INR | 0.0% |
| 2019 FY | 204.5 Billion INR | -24.32% |
| 2019 Q2 | 274.92 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 204.5 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 184.9 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 270.22 Billion INR | 0.0% |
| 2018 FY | 270.22 Billion INR | 11.55% |
| 2017 Q2 | 218.86 Billion INR | 0.0% |
| 2017 Q3 | 394.55 Billion INR | 80.27% |
| 2017 Q4 | 242.24 Billion INR | -38.6% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 242.24 Billion INR | 67.05% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 145.01 Billion INR | 91.28% |
| 2016 Q4 | 145.01 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 151.45 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 75.81 Billion INR | 100.16% |
| 2015 Q4 | 75.81 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 62.92 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 37.87 Billion INR | 0.0% |
| 2014 FY | 37.87 Billion INR | 41.34% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 35.58 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 28.85 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 26.79 Billion INR | 120.48% |
| 2013 Q4 | 26.79 Billion INR | 0.0% |
| 2012 FY | 12.15 Billion INR | 87.49% |
| 2012 Q4 | 12.15 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 6.91 Billion INR | 0.0% |
| 2011 Q4 | 6.48 Billion INR | 0.0% |
| 2011 FY | 6.48 Billion INR | -14.35% |
| 2010 FY | 7.56 Billion INR | -41.55% |
| 2009 FY | 12.94 Billion INR | -3.29% |
| 2008 FY | 13.39 Billion INR | 86.94% |
| 2007 FY | 7.16 Billion INR | 12.06% |
| 2006 FY | 6.39 Billion INR | 105.25% |
| 2005 FY | 3.11 Billion INR | -15.37% |
| 2004 FY | 3.68 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -85119.354% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -498225.429% |
| FDC Limited | 2.46 Million INR | -21729798.621% |
| Gufic Biosciences Limited | 1.53 Billion INR | -34704.398% |
| Jubilant Pharmova Limited | 31.67 Billion INR | -1591.956% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -38091.452% |
| Orchid Pharma Limited | 1.2 Billion INR | -44395.573% |
| Alkem Laboratories Limited | 400 Million INR | -133864.825% |
| Bajaj HealthCare Limited | 650.34 Million INR | -82296.159% |
| Brooks Laboratories Limited | 3.56 Million INR | -15031016.41% |
| Eris Lifesciences Limited | 6.54 Billion INR | -8087.22% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -362923.711% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -45528.346% |
| Innova Captab Limited | 2.1 Billion INR | -25354.08% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -708989.983% |
| Wanbury Limited | 820 Million INR | -65248.695% |
| Lupin Limited | 1.55 Billion INR | -34409.228% |
| Aarti Drugs Limited | 2.75 Billion INR | -19362.438% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -133964725.0% |
| Albert David Limited | 6.01 Million INR | -8907135.705% |
| Alembic Limited | 73.9 Million INR | -725014.073% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | -29379.587% |
| Hikal Limited | 4.22 Billion INR | -12572.562% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -479948.824% |
| Ind-Swift Limited | 10.09 Billion INR | -5208.147% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -401169.498% |
| Medico Remedies Limited | 8.67 Million INR | -6179089.345% |
| Morepen Laboratories Limited | 33.64 Million INR | -1592823.008% |
| Procter & Gamble Health Limited | 68.8 Million INR | -778765.262% |
| RPG Life Sciences Limited | -30.3 Million INR | 1768612.541% |
| Sigachi Industries Limited | 265.79 Million INR | -201503.962% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -4028917.293% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -252240.08% |
| Themis Medicare Limited | 267.74 Million INR | -200041.667% |
| Unichem Laboratories Limited | 382.22 Million INR | -140096.195% |
| Vaishali Pharma Limited | 35.98 Million INR | -1489101.289% |
| Venus Remedies Limited | 386.8 Million INR | -138436.531% |
| Windlas Biotech Limited | 20.18 Million INR | -2655297.919% |
| ZIM Laboratories Limited | 356 Million INR | -150419.738% |
| Sakar Healthcare Limited | 549.55 Million INR | -97408.744% |
| Aurobindo Pharma Limited | 21.34 Billion INR | -2409.997% |
| Divi's Laboratories Limited | 20 Million INR | -2679196.5% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1924958.557% |
| Mankind Pharma Limited | 325.81 Million INR | -164367.351% |
| Sequent Scientific Limited | 1.42 Billion INR | -37446.458% |
| Laurus Labs Limited | 7.98 Billion INR | -6613.094% |
| Neuland Laboratories Limited | 449.2 Million INR | -119190.326% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -226574.831% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -35225.715% |
| Zydus Lifesciences Limited | 251 Million INR | -213389.761% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -3836235.195% |
| Wockhardt Limited | 8.91 Billion INR | -5914.134% |
| Bal Pharma Limited | 363.82 Million INR | -147185.308% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -8845.898% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -150455.262% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -5824457.609% |
| Shilpa Medicare Limited | 5.6 Billion INR | -9466.185% |
| Valiant Laboratories Limited | 750.89 Million INR | -71262.367% |
| Ajanta Pharma Limited | 235.2 Million INR | -227731.335% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -1661800.474% |
| Granules India Limited | 689.71 Million INR | -77593.422% |
| Medicamen Biotech Limited | 12.55 Million INR | -4267994.783% |
| Ipca Laboratories Limited | 5.8 Billion INR | -9132.427% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 43959025.349% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | -3240.769% |
| NATCO Pharma Limited | 53 Million INR | -1010955.283% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -29102.142% |
| Strides Pharma Science Limited | 6.71 Billion INR | -7880.046% |
| Indoco Remedies Limited | 3.51 Billion INR | -15134.961% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -502582.27% |